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Abstract. Diarrheal diseases (DD) are leading causes of disease burden, death, and disability, especially in children
in low-income settings. DD can also impact a child’s potential livelihood through stunted physical growth, cognitive
impairment, and other sequelae. As part of the Global Burden of Disease Study, we estimated DD burden, and the
burden attributable to specific risk factors and particular etiologies, in the Eastern Mediterranean Region (EMR)
between 1990 and 2013. For both sexes and all ages, we calculated disability-adjusted life years (DALYs), which are
the sum of years of life lost and years lived with disability. We estimate that over 125,000 deaths (3.6% of total deaths)
were due to DD in the EMR in 2013, with a greater burden of DD in low- and middle-income countries. Diarrhea
deaths per 100,000 children under 5 years of age ranged from one (95% uncertainty interval [UI] = 0–1) in Bahrain
and Oman to 471 (95% UI = 245–763) in Somalia. The pattern for diarrhea DALYs among those under 5 years of age
closely followed that for diarrheal deaths. DALYs per 100,000 ranged from 739 (95% UI = 520–989) in Syria to 40,869
(95% UI = 21,540–65,823) in Somalia. Our results highlighted a highly inequitable burden of DD in EMR, mainly
driven by the lack of access to proper resources such as water and sanitation. Our findings will guide preventive and
treatment interventions which are based on evidence and which follow the ultimate goal of reducing the DD burden.
INTRODUCTION
Diarrheal diseases (DD) are a major cause of childhood
mortality globally, resulting in approximately 550,000 deaths
among children under 5 years of age each year.1 Although
mortality due to DD has declined significantly in children
over the past 20 years, the incidence of childhood diarrhea
in low-income countries (LICs) has not fallen appreciably.1
For those who survive these illnesses, repeated infections
by enteric pathogens in the early years of life can lead to
serious, lifelong health consequences such as environmen-
tal enteric dysfunction, growth faltering, impaired cognitive
development, reduced immune response to infection and
vaccinations, and death.2
Although a wide spectrum of bacterial, viral, and parasitic
pathogens are responsible for infectious diarrhea worldwide,
their etiologic contribution may vary depending on the geo-
graphic location of the study, study durations, or the popu-
lation sampled.3 In addition, variations in the reported
frequency of diarrhea may reflect the diagnostic tools used
rather than the actual incidence of each pathogen.4 Further-
more, coinfections are common and more than one pathogen
may be implicated in cases of diarrhea.
The Eastern Mediterranean Region (EMR) is home to
more than 500 million people, representing a diverse group
of 22 countries, including Arab states in north Africa, Gulf
nations, and countries in west Asia. EMR countries have
diverse historical backgrounds, political and social contexts,
and fiscal and cultural influences on their health-care sys-
tems. The region has wide variation in per capita gross
national product, ranging from a high of $134,420 in Qatar
to a low of $2,000 in Afghanistan.5 Such wide variation has
a major influence on overall health spending and results in
substantial health inequities both within and across countries.
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Furthermore, the region has witnessed long years of political
instability and conflicts, including the recent Arab Spring
uprising and conflicts in countries such as Syria and Yemen.
Many countries in the EMR achieved important suc-
cesses in the 1970s and 1980s with the support of the
United Nations International Children’s Emergency Fund
and the World Health Organization (WHO) through the
National Control of Diarrheal Diseases Project.6,7 For
example, Egypt’s program, which spanned from 1981 to
1991, was credited with significantly improving diarrheal
case management.8–10 However, over the last two decades,
the momentum has slowed.11 As of January 2016, rotavirus
vaccines have been introduced through national immuniza-
tion programs in only three (Djibouti, Republic of Sudan,
and Yemen) of 11 Gavi-eligible countries in the region.12
The perceived lack of urgency relative to the major politi-
cal and economic challenges facing the region has contrib-
uted to the current low level of awareness regarding the
remaining burden of diarrhea. To date, there remains a
lack of adequate research to address these diseases in many
EMR countries.
Our objective in this report is to establish the size of
the burden, distribution of pathogens, and risk factors
for diarrhea in children and adults in the EMR for 1990
through 2013.
MATERIALS AND METHODS
Study region. The EMR countries were grouped according
to per capita gross national income (GNI) into LICs (Islamic
Republic of Afghanistan [Afghanistan], Djibouti, Somalia,
Republic of Yemen [Yemen]); middle-income countries (MICs)
(Arab Republic of Egypt [Egypt], Islamic Republic of Iran
[Iran], Iraq, Jordan, Lebanon, Libya, Morocco, Pakistan,
Palestine, Sudan, Syrian Arab Republic [Syria], Tunisia);
and high-income countries (HICs) (Bahrain, Kuwait, Oman,
Qatar, Saudi Arabia, and the United Arab Emirates [UAE]).
We defined LICs as those having a per capita GNI of $1,045
or less, MICs as those with a per capita GNI between $1,046
and $12,735, and HICs as countries with per capita GNI
of $12,736 or greater.
Global burden of disease. The Global Burden of Disease
Study 2013 (GBD 2013) is a systematic, comprehensive
effort to quantify health loss from 306 causes of diseases and
injuries, 240 causes of death, and 79 risk factors by sex and
age groups between 1990 and 2013 for 188 countries. GBD
2013’s estimation process, including that for DD, has been
described in detail elsewhere.1 The burden of DD was mea-
sured in disability-adjusted life years (DALYs), the sum of
years of life lost due to premature death (YLLs) and years
lived with disability (YLDs). The methods used to calculate
each of these are summarized below.
Mortality. Cause-specific mortality estimates, including
those for DD, were modeled using a Bayesian ensemble
modeling process.13 Diarrhea mortality data included vital
registration and verbal autopsy sources. The modeling pro-
cess estimated the mortality rate due to diarrhea for both
genders from 1990 to 2013 for all age groups in every
country, and in subnational areas of some countries. Covar-
iates, such as improved water and sanitation sources, mal-
nutrition, and population density were considered. The
ensemble model approach allowed for a suite of models,
weighted by out-of-sample predictive validity, to inform the
final estimates.
Morbidity. As with mortality, morbidity is modeled at
every year, gender, age, and geographic location in the GBD
study. We used DisMod-MR 2.0, a Bayesian meta-regression
mixed effects model, to calculate morbidity. DisMod-MR
was originally developed for GBD 2010 to address statistical
challenges in estimating nonfatal health outcomes and syn-
thesizing sparse and heterogeneous epidemiological data.
It uses nonlinear mixed effects models that include country-
and study-level covariates to generate priors for increasingly
detailed geographic regions in an analytic cascade. Preva-
lence, incidence, recovery, and death are related in a series
of ordinary differential equations within DisMod-MR. Basi-
cally, it is a mathematical modeling technique that takes data
collected from different sources, corrects for inconsistencies,
and fills in gaps when data are incomplete, ultimately pro-
ducing estimates of disease burden by age, sex, and country.
A full description of DisMod-MR is available elsewhere.14–16
Diarrhea prevalence and incidence data from a system-
atic literature review and population-representative surveys
informed the meta-analytic model and estimates.
Etiologies. Diarrhea cases and deaths were attributed to
pathogens using a counterfactual approach. A systematic lit-
erature review on the proportion of diarrhea cases that test
positive for a set of pathogens is used in the DisMod-MR
framework to estimate the age, sex, year, and geographic dis-
tribution of diarrheal pathogens. The population-attributable
fraction (PAF) is used to parse the fraction of diarrhea cases
and deaths due to each pathogen. The PAF is calculated as
PAF ¼ proportion 1 ½1=odds ratio; ð Þ
Where “proportion” is the proportion of cases positive for
a pathogen and “odds ratio” (OR) is the odds of diarrhea
given pathogen detection. The ORs were derived from the
Global Enteric Multicenter Study (GEMS), a multisite
case-control study of moderate-to-severe diarrhea in children
under 5 years of age,17 using a mixed effects conditional
logistic regression model. With the exception of Pakistan,
where the ORs were calculated from a model including only
the Pakistan GEMS site, the ORs were calculated from a
model that included all GEMS sites.
Vibrio cholerae and Clostridium difficile were estimated
separately from the other pathogens in GBD. Cholera cases
were estimated using data from previous studies compared
with WHO case notification data to estimate underreporting.
Cholera deaths were estimated using case fatality data in
DisMod-MR. Since C. difficile is frequently associated with
hospital and health-care utilization, hospital incidence data
were modeled in DisMod-MR 2.0.
Risk factors. We also assessed diarrheal DALYs, YLLs,
and YLDs attributable to childhood stunting (below −2 stan-
dard deviations of the median height of a reference popula-
tion), suboptimal breastfeeding (nonexclusive breastfeeding
and discontinued breastfeeding), vitamin A deficiency, zinc
deficiency, and water, sanitation, and hygiene (WASH).
Data analysis. The average decrease in deaths, DALYs,
YLLs, and YLDs was calculated by subtracting the mean
estimate in 1990 from the mean estimate in 2013, divided by
23 years. All reported rates are per 100,000 persons and are
not age standardized. Uncertainty for deaths, DALYs, and
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attributable fractions in GBD were derived from 1,000 draws
of the variables used to estimate these outcomes. For exam-
ple, the ORs, pathogen prevalence among diarrhea cases,
and mortality rates are from normal or log-normal distri-
butions and were combined at the draw level to estimate
pathogen-specific diarrhea mortality. The 95% uncertainty
intervals (UIs) then are the 2.5 and 97.5 percentiles of these
estimates. This analysis was conducted using Stata/SE 13.1
(StataCorp LP, College Station, TX) and maps were gener-
ated using the ggplot218 package in R 3.2.2 (R Foundation
for Statistical Computing, Vienna, Austria).
RESULTS
Deaths. There were 128,024 (95% UI = 88,729–172,361)
diarrhea-related deaths in the EMR in 2013, with an over-
all rate of 21 diarrheal deaths per 100,000 persons (95%
UI = 14–28) (Table 1). The majority of these deaths occurred
among children under 5 years of age (68.9%) (88,172, 95%
UI = 52,794–129,711) and adults over 70 years of age
(11.9%) (15,278, 95% UI = 9,491–22,518). There were no
consistent differences in diarrhea deaths per 100,000 between
males and females (Supplemental Figure 1). There were
some exceptions to the general pattern of children under
5 years of age bearing the greatest burden. In Djibouti, in
the year 2000, diarrhea deaths per 100,000 were greater among
those over 70 years of age (680, 95% UI = 394–1,088) than
among those under 5 years of age (187, 95% UI = 84–332). In
neighboring Somalia, death rates were also higher for individ-
uals over 70 years of age versus individuals under 5 years
of age at each time point.
Graphs of diarrhea deaths per 100,000 demonstrated a
steady decrease from 1990 to 2013, with the most notable
declines among children under 5 years of age and individuals
≥ 70 years of age (Figure 1). For all ages, diarrhea death
rates decreased by an average of 2.39% deaths per 100,000
per year during this period. For those under 5, 5–14, 15–49,
50–69, and over 70 years of age, the average decrease in the
diarrheal death rate was 11.17%, 0.39%, 0.17%, 0.78%, and
4.96% per 100,000 per year, respectively. The 2013 diarrhea-
associated death rates were stratified by country and
per capita GNI (Figure 2). Diarrhea deaths per 100,000
children under 5 years of age ranged from one (95%
UI = 0–1), in Bahrain and Oman (HICs), to 471 (95%
UI = 245–763), in Somalia (a LIC) (Supplemental
Table 1). Among MICs, Pakistan (225, 95% UI = 144–315)
and Sudan (120, 95% UI = 61–189) had diarrhea death rates
in excess of their economic peers. Overall, diarrhea mortality
appeared to be related to per capita GNI rather than geo-
graphical location.
Years of life lost due to premature mortality. Nearly
9 million (8,935,214, 95% UI = 5,865,116–12,571,874) YLLs
were attributable to diarrhea in the EMR in 2013. Children
under 5 years of age bore the majority (84.5%) of this bur-
den (7,553,654, 95% UI = 4,517,051–11,112,683), and had a
rate of 10,361 (95% UI = 6,196–15,242) YLLs per 100,000.
Children under 5 years of age in Bahrain (57, 95% UI = 34–
88), Oman (59, 95% UI = 31–108) and Qatar (95, 95% UI =
53–167) experienced the lowest rates of YLLs per 100,000
in the region. On the other hand, children in Somalia
(40,238, 95% UI = 20,975–65,112) and Afghanistan (20,675,
95% UI = 11,160–31,515), two countries with the longest
history of ongoing civil wars in the region, experienced the
highest rates.
Years lived with disability. Diarrhea was responsible for
a total of 1,002,096 (95% UI = 673,662–1,392,552) YLDs
in 2013 in the region, with children under 5 years of age
contributing more than half of this burden (586,935, 95%
UI = 391,944–820,782). The rate of YLDs per 100,000 among
children under 5 years of age was 805 (95% UI = 538–1,126)
and ranged from 177 (95% UI = 106–263) in Djibouti to 974
(95% UI = 662–1,357) in Afghanistan.
Disability-adjusted life years. Nearly 10 million DALYs
were attributable to diarrhea (9,937,310, 95% UI = 6,802,456–
13,650,080), with an overall rate of 1,610 (95% UI = 1,102–
2,212) DALYs per 100,000 in the EMR in 2013 (Table 2).
The majority of DALYs were borne by those under 5 years
of age (81.9%) (8,140,589, 95% UI = 5,082,597–11,726,801)
and those 15–49 years of age (7.4%) (737,925, 95% UI =
498,093–1,058,052). There were no consistent differences in
diarrhea-associated DALYs between males and females.
The average decrease in the number of DALYs over this
time period in the region as a whole was 568,035 per year,
with the majority of this decrease among those under 5 and
5–14 years of age (543,789 and 23,734 DALYs per year,
respectively). The pattern for diarrhea DALYs among those
under 5 years of age closely followed that for diarrheal
deaths. DALY rates ranged from 739 (95% UI = 520–989) in
Syria to 40,869 (95% UI = 21,540–65,823) in Somalia.
In each country, diarrhea DALYs decreased over time and
children under 5 years of age consistently contributed the
majority of diarrheal DALYs (Supplemental Figure 2).
Etiologies. The proportion of deaths attributable to spe-
cific etiologies in 2013, excluding cholera and C. difficile,
are presented in Figure 3. Generally, rotavirus infection
was the largest contributor to the diarrheal burden of dis-
ease. However, Shigella was the greatest contributor to diar-
rheal deaths and DALYs in Sudan. When also considering
cholera and C. difficile, the total proportion of attributable
deaths was greater than 100% (more than one attributable
TABLE 1
Diarrheal disease-associated deaths in the EMR, 2013
Age
(years) Sex Deaths (UI) Rate* (UI) % of total†
All ages Male 64,690 (38,893–95,066) 20 (12–30) 3.29
Female 63,334 (38,706–92,897) 21 (13–31) 3.88
Total 128,024 (88,729–172,361) 21 (14–28) 3.56
< 5 Male 44,346 (20,941–72,951) 118 (56–195) 11.19
Female 43,826 (21,668–71,417) 124 (61–201) 12.70
Total 88,172 (52,794–129,711) 121 (72–178) 11.90
5–14 Male 2,484 (1,113–4,690) 4 (2–7) 4.68
Female 3,105 (1,467–5,590) 5 (2–9) 7.17
Total 5,589 (3,175–9,011) 4 (2–7) 5.80
15–49 Male 4,634 (2,381–7,942) 3 (1–5) 1.14
Female 4,878 (2,537–8,189) 3 (2–5) 1.81
Total 9,512 (5,765–14,738) 3 (2–4) 1.41
50–69 Male 5,091 (2,584–8,884) 15 (8–27) 0.97
Female 4,383 (2,105–7,859) 13 (6–24) 1.13
Total 9,474 (5,487–15,012) 14 (8–23) 1.04
70+ Male 8,136 (4,253–13,493) 106 (55–175) 1.38
Female 7,142 (3,800–12,096) 83 (44–140) 1.22
Total 15,278 (9,491–22,518) 94 (58–138) 1.30
EMR = Eastern Mediterranean Region; UI = uncertainty interval.
*Rate is per 100,000.
†Percent of total deaths in the EMR for the specified age group and sex.
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pathogen per diarrheal episode) for Jordan, Palestine, Syria,
Bahrain, and Oman (Supplemental Figure 3). These same
five countries also had a relatively large proportion of diar-
rheal deaths attributed to cholera in 2013 and an increasing
cholera burden in the recent years (Supplemental Figure 4).
Graphs of the relative proportions of known etiologies lead-
ing to diarrheal DALYs for children under 5 years of age are
provided in Supplemental Figure 5.
Risk factors. In 2013, the two risk factors that con-
tributed to the greatest number of diarrhea-attributable
deaths (Supplemental Figure 6) and DALYs (Supplemen-
tal Figure 7) among those under 5 years of age were
WASH and suboptimal breastfeeding. Rates of suboptimal
breastfeeding–related deaths ranged from zero (0, 95%
UI = 0–1) in Bahrain and Oman to 232 (95% UI = 105–
405) in Somalia. The same pattern was seen with rates of
WASH-related deaths, where Bahrain and Oman had a
rate of one (95% UI = 0–1) and Somalia’s rate was 457
(95% UI = 238–734). WASH-related deaths and DALYs
were somewhat greater in LICs, and the burden due to
FIGURE 1. Diarrheal disease-associated deaths in the Eastern Mediterranean Region, 1990–2013.
FIGURE 2. Diarrheal disease-associated death rates among children under 5 years of age in the Eastern Mediterranean Region, sorted by low,
middle, and high income per capita gross national income, 2013.
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suboptimal breastfeeding was generally greater in HICs
(Supplemental Figures 8 and 9).
DISCUSSION
We reported the most comprehensive assessment of DD
burden and the contributions of specific pathogens and risk
factors in the EMR to date. In 2013, the estimated diarrhea-
associated deaths and DALYs were more than 125,000 and
nearly 10 million, respectively. We also found substantial var-
iation within the region, with LICs and MICs experiencing
social unrest bearing the vast majority of diarrheal burden.
Our estimates are comparable with others from recent
publications. A systematic literature review published in
2008 estimated diarrhea deaths among those under 5 years
of age in 13 EMR countries (Bahrain, Cyprus, Iran, Jordan,
Kuwait, Lebanon, Libya, Oman, Qatar, Saudi Arabia, Syria,
Tunisia, and the UAE) to be 12,000 (UI = 10,000–14,000),
and in nine other EMR countries (Afghanistan, Djibouti,
Egypt, Iraq, Morocco, Pakistan, Somalia, Sudan, and Yemen)
to be 221,000 (UI = 190,000–250,000).19 Our estimated num-
ber of DD-associated deaths in this age group, which com-
bines these two subregions, was similar. In addition, although
we did not follow the same grouping of countries in our
FIGURE 3. The proportion of diarrheal deaths due to known pathogens,* among children under 5 years of age in the Eastern Mediterranean
Region, 2013 (*excluding cholera and Clostridium difficile).
TABLE 2
Diarrheal disease-associated DALYs in the Eastern Mediterranean Region, 2013
Age
(years) Sex DALYs (UI) Rate* (UI) % of total†
All ages Male 5,003,063 (2,917,614–7,527,475) 1,575 (918–2,369) 4.51
Female 4,934,247 (2,959,335–7,385,260) 1,648 (988–2,466) 5.14
Total 9,937,310 (6,802,456–13,650,080) 1,610 (1,102–2,212) 4.80
< 5 Male 4,110,927 (2,083,037–6,565,118) 10,979 (5,563–17,533) 11.50
Female 4,029,662 (2,105,785–6,409,279) 11,363 (5,938–18,073) 12.97
Total 8,140,589 (5,082,597–11,726,801) 11,166 (6,971–16,085) 12.19
5–14 Male 267,327 (148,924–452,243) 400 (223–678) 3.33
Female 306,681 (169,331–506,004) 486 (268–802) 4.45
Total 574,008 (367,111–863,442) 442 (283–665) 3.84
15–49 Male 363,936 (223,641–561,754) 211 (130–326) 0.96
Female 373,988 (224,349–577,646) 235 (141–363) 1.16
Total 737,925 (498,093–1,058,052) 222 (150–319) 1.05
50–69 Male 158,484 (87,613–261,122) 476 (263–785) 0.78
Female 134,679 (72,309–228,946) 407 (219–692) 0.80
Total 293,163 (182,407–446,130) 442 (275–672) 0.79
70+ Male 102,390 (57,014–165,506) 1,330 (741–2,150) 1.15
Female 89,236 (51,181–142,531) 1,035 (593–1,652) 1.01
Total 191,626 (124,949–275,176) 1,174 (765–1,686) 1.08
DALY = disability-adjusted life years; EMR = Eastern Mediterranean Region; UI = uncertainty interval.
*Rate is per 100,000.
†Percent of total DALYs in the EMR for the specified age group and sex.
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study, the countries for which we estimated the highest diar-
rhea burden were all included in the “high-mortality” coun-
tries according to the study. In addition, a 2013 publication
estimated the number of DD-associated deaths in the EMR
among children under 5 years of age in 2011 to be 96,000
(UI = 64,200–153,300).20 This is comparable to our finding of
88,172 (UI = 52,794–129,711) and suggests a slight increase
in the number of deaths.
Our data clearly illustrated the gross health inequity in the
region, with HICs experiencing a nominal diarrhea burden
compared with the substantial burden in all LICs and some
MICs. However, what cannot be observed in our data are
the potential inequities in access to infrastructure and ser-
vices within individual countries of the EMR. Not only do
wealthier and urban communities have better access to
proper infrastructure for water and sanitation, they also tend
to have the education and financial resources to properly
use point-of-use water treatment modalities. Furthermore,
the introduction of vaccines against diarrheal pathogens may
exacerbate inequalities in diarrhea burden. For example,
although rotavirus infection was the largest contributor to
the diarrheal burden of disease, in some countries in the
region, rotavirus vaccine is only available in the private mar-
ket. This means that wealthier families, who have less need
for the vaccine, will gain the primary benefit from its avail-
ability. This is troubling because economic analyses of rota-
virus vaccine introduction among a number of EMR countries
have uniformly suggested that vaccine introduction would be
cost-beneficial from a societal perspective.6,21–23 One study
in Somalia (the only LIC country) suggested that introduc-
tion of a rotavirus as special immunization program during a
complex humanitarian emergency would meet WHO cost-
effectiveness benchmarks.24
A unique contribution of this analysis is the inclusion
of all age groups. Due to the high disease burden in young
children, nearly all diarrhea interventions and most diar-
rhea burden studies are limited to those under 5 years of
age.19,20,25 However, the burden among those over 70 years
of age is substantial, with DD-associated deaths totaling
nearly one-sixth of the number among those under 5 years
of age. The elderly may face increased diarrhea risk due to
immunosenescence and comorbidities, which may also neces-
sitate special consideration in their treatment.26 The increas-
ing nature of cholera burden in five EMR countries (Jordan,
Palestine, Syria, Bahrain, and Oman) is a cause of concern,
as neighboring countries remain at a high risk of transmis-
sion due to presence and movement of refugee populations
among them.
We found no systematic difference in under-5 diarrhea
deaths or DALYs when comparing females to males. We
hypothesized that there may exist evidence of differential
diarrhea mortality burden by sex. A previous analysis of
global demographic and health survey (DHS) data reported
that girls 1–4 years of age, particularly in the Middle Eastern
crescent, are at a mortality disadvantage compared with
boys,27 perhaps due to differences in health-care access and
nutritional status. Furthermore, an Egyptian study found
some evidence that, even when parents sought care for their
daughters with diarrhea, regional health-care providers pro-
vided biased treatment in favor of boys.28 However, more
recent publications, such as a 2009 verbal autopsy study in
Iraq, found no difference in under-5 mortality by sex.29
Our study has several limitations and strengths. First,
while our modeling process seeks to make use of all avail-
able data, the number of relevant publications in the region
is limited and unbalanced between countries. However, our
hierarchical modeling approach allows us to “borrow” strength
across time and geography to generate the best possible esti-
mates. Second, since we only account for the acute phase of
diarrhea in our YLD estimates, the resulting DALYs severely
underestimate diarrhea-associated morbidity. In GBD 2016,
we expect to include long-term sequelae such as stunting and
cognitive impairment,30,31 which will better estimate the true
burden of disease. Third, the reported distribution of diarrhea
etiologies was based on traditional laboratory detection tech-
niques,17 which may be less sensitive and specific than molec-
ular methods. For this reason, our future GBD estimates
will incorporate a GEMS reanalysis based on standardized
quantitative polymerase chain reaction data for all patho-
gens.32 Despite these limitations, this analysis also has several
strengths. GBD methodology ensures internal consistency
so that morbidity and mortality cannot be simultaneously
ascribed to competing causes and allows for comparability
between countries and across regions.
CONCLUSIONS
Although there were substantial improvements in DD-
related morbidity and mortality, the health inequities revealed
in our data show that more action is needed to reduce the bur-
den of diarrhea in the EMR, especially in lower-income coun-
tries and countries experiencing political and social unrest.
A coordinated approach that involves prevention and treat-
ment is needed to address the multiple causes of DD. Regional
health systems need to be strengthened to achieve the wide-
spread availability and use of oral rehydration salts, improved
rates of breastfeeding, improved nutrition, better sanitation
and hygiene, and increased coverage of measles immunization.
Due to the high relevance of rotavirus infections in EMR,33
there is also an urgent need to roll out rotavirus vaccine in
the region through government immunization programs that
would ensure access for the children who are most in need.
In addition, regional governments should begin deliberation
to integrate Shigella, enterotoxigenic Escherichia coli, and
other diarrheal vaccines that are currently in preclinical and
clinical trials into their expanded programs on immunization
as soon as they are approved and licensed.
Received April 29, 2016. Accepted for publication July 3, 2016.
Published online October 10, 2016.
Note: Supplemental table and figures appear at www.ajtmh.org.
Acknowledgments: The Institute for Health Metrics and Evaluation
would like to thank Adrienne Chew for copyediting this manuscript.
Financial support: This study was supported by the Bill & Melinda
Gates Foundation. Katherine B. Gibney received the NHMRC
Gustav Nossal Postgraduate Scholarship sponsored by CSL in 2012.
This award is peer-reviewed through the standard NHMRC peer-
review process.
Disclaimer: CSL (now Sequirus) does not play any part in the
selection of the awardee. The views expressed by Mark Riddle
in this article do not necessarily reflect the official policy or position
of the Department of the Navy, Department of Defense, or the
U.S. Government.
Authors’ addresses: Ibrahim Khalil, Danny V. Colombara, Mohammad
Hossein Forouzanfar, Christopher Troeger, Farah Daoud, Charbel
1325BURDEN OF DIARRHEA IN THE EMR, 1990–2013
El Bcheraoui, Puja C. Rao, Ashkan Afshin, Raghid Charara, Awoke
Misganaw, Haidong Wang, Mohsen Naghavi, Theo Vos, Christopher
J. L. Murray, and Ali H. Mokdad, Institute for Health Metrics
and Evaluation, University of Washington, Seattle, WA, E-mails:
ikhalil@uw.edu, dvc2@uw.edu, forouzan@uw.edu, ctroeger@uw.edu,
farahd@uw.edu, charbel@uw.edu, pujarao@uw.edu, aafshin@uw.edu,
raghidc@uw.edu, awoket@uw.edu, haidong@uw.edu, nagham@uw
.edu, tvos@uw.edu, cjlm@uw.edu, and mokdaa@uw.edu. Maziar
Moradi-Lakeh, Institute for Health Metrics and Evaluation, Univer-
sity of Washington, Seattle, WA, and Department of Community
Medicine, Gastrointestinal and Liver Disease Research Center, Iran
University of Medical Sciences, Tehran, Iran, E-mail: mmoradi@uw
.edu. Kalkidan Hassen Abate, Jimma University, Jimma, Ethiopia,
E-mail: kalkidan.hassen@ju.edu.et. Mohammed Magdy Abd El Razek,
Aswan Faculty of Medicine, Aswan, Egypt, E-mail: hoda_734@
hotmail.com. Foad Abd-Allah, Department of Neurology, Cairo
University, Cairo, Egypt, E-mail: foad.abdallah@kasralainy.edu.eg.
Remon Abu-Elyazeed, GlaxoSmithKline, Philadelphia, PA, E-mail:
remon.abu-elyazeed@gsk.com. Aliasghar Ahmad Kiadaliri, Clinical
Epidemiology Unit, Orthopedics, Department of Clinical Sciences
Lund, Lund University, Lund, Sweden, and Health Services Manage-
ment Research Center, Institute for Futures Studies in Health,
Kerman University of Medical Sciences, Kerman, Iran, E-mail:
aliasghar.ahmad_kiadaliri@med.lu.se. Ali Shafqat Akanda, Univer-
sity of Rhode Island, Kingston, RI, E-mail: akanda@egr.uri.edu.
Nadia Akseer, Hospital for Sick Children, Toronto, Canada, and
University of Toronto, Toronto, Canada, E-mail: nadia.akseer@
sickkids.ca. Khurshid Alam, Murdoch Children’s Research Insti-
tute, Melbourne, Australia, University of Melbourne, Melbourne,
Australia, and University of Sydney, Sydney, Australia, E-mail:
khurshid.bd@gmail.com. Deena Alasfoor, Ministry of Health, Al
Khuwair, Oman, E-mail: deena.alasfoor@me.com. Raghib Ali, Uni-
versity of Oxford, Oxford, United Kingdom, E-mail: raghib.ali@ndm
.ox.ac.uk. Mohammad A. AlMazroa and Abdullah A. Al Rabeeah,
Kingdom of Saudi Arabia Ministry of Health, Riyadh, Saudi Arabia,
E-mails: maalmazroa@hotmail.com. Mahmoud A. Alomari, Division of
Physical Therapy, Department of Rehabilitation Sciences, Jordan Uni-
versity of Science and Technology, Irbid, Jordan, E-mail: lsualomari@
gmail.com. Rajaa Mohammad Salem Al-Raddadi, Ministry of Health,
Jeddah, Saudi Arabia, E-mail: saudiresearcher@yahoo.com. Ubai
Alsharif, Charité Universitätsmedizin, Berlin, Germany, E-mail:
ubai.al-sharif@charite.de. Shirina Alsowaidi, Department of Inter-
nal Medicine, College of Medicine and Health Sciences, United
Arab Emirates University, Al-Ain, United Arab Emirates, E-mail:
shirina.alsowaidi@uaeu.ac.ae. Khalid A. Altirkawi, King Saud
University, Riyadh, Saudi Arabia, E-mail: kaltirkawi@ksu.edu.sa.
Nelson Alvis-Guzman, Universidad de Cartagena, Cartagena de
Indias, Colombia, E-mail: nalvis@yahoo.com. Walid Ammar and
Hilda L. Harb, Ministry of Public Health, Beirut, Lebanon, E-mails:
wammarmd@gmail.com and hilda_harb@yahoo.com. Carl Abelardo
T. Antonio, Department of Health Policy and Administration,
College of Public Health, University of the Philippines, Manila,
Philippines, E-mail: ctantoniomd@gmail.com. Hamid Asayesh,
Department of Medical Emergency, School of Paramedic, Qom
University of Medical Sciences, Qom, Iran, E-mail: asayeshpsy@
gmail.com. Rana Jawad Asghar, South Asian Public Health Forum,
Islamabad, Pakistan, E-mail: jawad@alumni.washington.edu. Suleman
Atique, Graduate Institute of Biomedical Informatics, Taipei Medical
University, Taipei, Taiwan, E-mail: gcufpharmd@yahoo.com. Ashish
Awasthi, Sanjay Gandhi Postgraduate Institute of Medical Sciences,
Lucknow, India, E-mail: ashishbhuims@gmail.com. Umar Bacha,
School of Health Sciences, University of Management and Tech-
nology, Lahore, Pakistan, E-mail: umar.bacha@umt.edu.pk. Alaa
Badawi, Public Health Agency of Canada, Toronto, Canada, E-mail:
a.e.badawi@gmail.com. Aleksandra Barac, Faculty of Medicine, Uni-
versity of Belgrade, Belgrade, Serbia, E-mail: aleksandrabarac85@
gmail.com. Neeraj Bedi, College of Public Health and Tropical
Medicine, Jazan, Saudi Arabia, E-mail: drnbedi@yahoo.com. Tolesa
Bekele, Madawalabu University, Bale Goba, Ethiopia, E-mail:
tolesa2003@yahoo.com. Isabela M. Bensenor, University of São
Paulo, São Paulo, Brazil, E-mail: isabensenor@gmail.com. Balem
Demtsu Betsu, Mekelle University, Mekelle, Ethiopia, E-mail:
balemdim@gmail.com. Zulfiqar Bhutta, Medical Center, Aga Khan
University, Karachi, Pakistan, and The Hospital for Sick Children,
Toronto, Canada, E-mail: zulfiqar.bhu0tta@aku.edu. Aref A. Bin
Abdulhak, University of Iowa Hospitals and Clinics, Iowa City,
IA, E-mail: aref146@gmail.com. Zahid A. Butt, Al Shifa Trust Eye
Hospital, Rawalpindi, Pakistan, E-mail: zabutt3@yahoo.com. Hadi
Danawi, Walden University, Minneapolis, MN, E-mail: hdanawi@
aol.com. Manisha Dubey, International Institute for Population Sci-
ences, Mumbai, India, E-mail: manikvdlw@gmail.com. Aman Yesuf
Endries, Arba Minch University, Arba Minch, Ethiopia, E-mail:
amanyesuf@gmail.com. Imad D. A. Faghmous, London School of
Hygiene and Tropical Medicine, London, United Kingdom, E-mail:
imaddean@doctors.org.uk. Talha Farid and Abdur Rahman Khan,
University of Louisville, Louisville, KY, E-mails: talha101@gmail
.com and abdur.khan@louisville.edu. Maryam S. Farvid, Harvard
T.H. Chan School of Public Health, Harvard University, Boston, MA,
and Institute for Health Policy, Boston, MA, E-mail: mfarvid@hsph
.harvard.edu. Farshad Farzadfar, Non-Communicable Diseases
Research Center, Endocrinology and Metabolism Research Insti-
tute, Tehran University of Medical Sciences, Tehran, Iran, E-mail:
farzadfar3@yahoo.com. Seyed-Mohammad Fereshtehnejad, Depart-
ment of Neurobiology, Care Sciences and Society, Karolinska Insti-
tute, Stockholm, Sweden, E-mail: sm.fereshtehnejad@ki.se. Florian
Fischer, Bielefeld University, Bielefeld, Germany, E-mail: f.fischer@
uni-bielefeld.de. Joseph Robert Anderson Fitchett, Harvard Univer-
sity, Boston, MA, E-mail: joseph@mail.harvard.edu. Katherine B.
Gibney, Department of Epidemiology and Preventive Medicine,
Monash University, Melbourne, Australia, and Melbourne Health,
Parkville, Australia, E-mail: katherine.gibney@monash.edu. Ibrahim
Abdelmageem Mohamed Ginawi, College of Medicine, University
of Hail, Hail, Saudi Arabia, Melkamu Dedefo Gishu, Haramaya
University, Dire Dawa, Ethiopia, and Kersa Health and Demo-
graphic Surveillance System, Harar, Ethiopia, E-mail: iginawi71@
gmail.com. Harish Chander Gugnani, Department of Microbiology,
Saint James School of Medicine, Anguilla, British West Indies,
and Department of Epidemiology and Biostatistics, Saint James
School of Medicine, Anguilla, British West Indies, E-mail: harish
.gugnani@gmail.com. Rahul Gupta, West Virginia Bureau for Public
Health, Charleston, WV, E-mail: rahul.gupta@wv.gov. Gessessew
Bugssa Hailu, Mekelle University, Mekelle, Ethiopia, and Kilte
Awlaelo Health and Demographic Surveillance System, Ethiopia,
E-mail: bugssag@gmail.com. Randah Ribhi Hamadeh, Arabian Gulf
University, Manama, Bahrain, E-mail: randah@agu.edu.bh. Samer
Hamidi, Hamdan Bin Mohammed Smart University, Dubai, United
Arab Emirates, E-mail: s.hamidi@hbmsu.ac.ae. Mohammad T.
Hedayati, Department of Medical Mycology and Parasitology,
School of Medicine, Mazandaran University of Medical Sciences,
Sari, Iran, E-mail: hedayatimt@gmail.com. Mohamed Hsairi, Depart-
ment of Epidemiology, Salah Azaiz Institute, Tunis, Tunisia, E-mail:
mohamed.hsairi@rns.tn. Abdullatif Husseini, Qatar University, Doha,
Qatar, E-mail: abdullatifh@gmail.com. Nader Jahanmehr, Department
of Public Health, School of Public Health, Shahid Beheshti Univer-
sity of Medical Sciences, Tehran, Iran, E-mail: n.jahanmehr@gmail
.com. Mehdi Javanbhakt, University of Aberdeen, Aberdeen, United
Kingdom, E-mail: javanbakhtm@gmail.com. Tariku Jibat, Addis Ababa
University, Debre Zeit, Ethiopia, and Wageningen University,
Wageningen, Netherlands, E-mail: jibattariku@gmail.com. Jost B.
Jonas, Department of Ophthalmology, Medical Faculty Mannheim,
Ruprecht-Karls-University Heidelberg, Mannheim, Germany, E-mail:
jost.jonas@medma.uni-heidelberg.de. Amir Kasaeian, Hematology-
Oncology and Stem Cell Transplantation Research Center, Tehran
University of Medical Sciences, Tehran, Iran, and Non-Communicable
Diseases Research Center, Endocrinology and Metabolism Research
Institute, Tehran University of Medical Sciences, Tehran, Iran, E-mail:
amir_kasaeian@yahoo.com. Yousef Saleh Khader, Jordan University
of Science and Technology, Irbid, Jordan, E-mail: yskhader@just
.edu.jo. Ejaz Ahmad Khan, Health Services Academy, Islamabad,
Pakistan, E-mail: ejaz@hsa.edu.pk. Gulfaraz Khan, Department of
Microbiology and Immunology, College of Medicine and Health
Sciences, United Arab Emirates University, Al Ain, United Arab
Emirates, E-mail: g_khan@uaeu.ac.ae. Tawfik Ahmed Muthafer
Khoja, Executive Board of the Health Ministers’ Council for Cooper-
ation Council States, Riyadh, Saudi Arabia, E-mail: sgh@sgh.org.sa.
Yohannes Kinfu, Centre for Research and Action in Public Health,
Faculty of Health, University of Canberra, Canberra, Australia,
E-mail: yohannes.kinfu@canberra.edu.au. Niranjan Kissoon and Farshad
Pourmalek, University of British Columbia, Vancouver, Canada, E-mails:
nkissoon@cw.bc.ca and farshad.pourmalek@ubc.ca. Ai Koyanagi,
1326 KHALIL AND OTHERS
Research and Development Unit, Parc Sanitari Sant Joan de Deu
(CIBERSAM), Barcelona, Spain, E-mail: a.koyanagi@pssjd.org. Aparna
Lal, Australian National University, Canberra, Australia, E-mail:
aparna.lal@anu.edu.au. Asma Abdul Abdul Latif, Department of
Zoology, Lahore College for Women University, Lahore, Pakistan,
E-mail: asma5latif@hotmail.com. Raimundas Lunevicius, Aintree
University Hospital, National Health Service Foundation Trust,
Liverpool, United Kingdom, and School of Medicine, University of
Liverpool, Liverpool, United Kingdom, E-mail: rlunevichus@yahoo
.com. Hassan Magdy Abd El Razek, Mansoura Faculty of Medi-
cine, Mansoura, Egypt, E-mail: farreha2013@hotmail.com. Azeem
Majeed, Imperial College London, London, United Kingdom,
E-mail: a.majeed@imperial.ac.uk. Reza Malekzadeh and Sadaf G.
Sepanlou, Digestive Disease Research Institute, Tehran Univer-
sity of Medical Sciences, Tehran, Iran, E-mails: malek@tums.ac.ir
and sepanlou@yahoo.com. Alem Mehari, Howard University Col-
lege of Medicine, Washington, DC, E-mail: alem.mehari@howard
.edu. Alemayehu B. Mekonnen, University of Gondar, Gondar,
Ethiopia, and University of Sydney, Sydney, Australia, E-mail:
aber5592@uni.sydney.edu.au. Yohannes Adama Melaku, School of
Public Health, Mekelle University, Mekelle, Ethiopia, and School
of Medicine, University of Adelaide, Adelaide, Australia, E-mail:
adamayohannes@gmail.com. Ziad A. Memish, Saudi Ministry of
Health, Riyadh, Saudi Arabia, and College of Medicine, Alfaisal
University, Riyadh, Saudi Arabia, E-mail: zmemish@yahoo.com.
Walter Mendoza, United Nations Population Fund, Lima, Peru,
E-mail: mendoza@unfpa.org. Layla Abdalla Ibrahim Mohamed,
Federal Ministry of Health, Khartoum, Sudan, E-mail: drlayla@hotmail
.com. Jean B. Nachega, University of Pittsburgh Graduate School of
Public Health, Pittsburgh, PA, and Stellenbosch University, Cape
Town, Western Cape, South Africa, E-mail: jnachega@jhsph.edu.
Quyen Le Nguyen, Institute for Global Health Innovations, Duy
Tan University, Da Nang, Vietnam, E-mail: quyen.ighi@gmail.com.
Muhammad Imran Nisar, Aga Khan University, Karachi, Pakistan,
E-mail: imran.nisar@aku.edu. Emmanuel Kwame Peprah, National
Heart, Lung, and Blood Institute, Bethesda, MD, E-mail: emmanuel
.peprah@nih.gov. James A. Platts-Mills, University of Virginia,
Charlottesville, VA, E-mail: jp5t@virginia.edu. Mostafa Qorbani,
Department of Community Medicine, School of Medicine, Alborz
University of Medical Sciences, Karaj, Iran, E-mail: mqorbani1379@
gmail.com. Anwar Rafay and Saleem M. Rana, Contech Interna-
tional Health Consultants, Lahore, Pakistan, and Contech School of
Public Health, Lahore, Pakistan, E-mails: rafay.aku.epibio@gmail
.com and smrmep@gmail.com. Vafa Rahimi-Movaghar, Sina Trauma
and Surgery Research Center, Tehran University of Medical Sci-
ences, Tehran, Iran, E-mail: v_rahimi@tums.ac.ir. Sajjad Ur Rahman,
Hamad Medical Corporation, Doha, Qatar, E-mail: sajjadjan@
hotmail.com. Rajesh Kumar Rai, Society for Health and Demo-
graphic Surveillance, Suri, India, E-mail: rajesh.iips28@gmail.com.
Chhabi L. Ranabhat, Wonju College of Medicine, Yonsei University,
Wonju, South Korea, and Institute for Poverty Alleviation and Inter-
national Development, Yonsei University, Wonju, South Korea,
E-mail: chhabir@gmail.com. Sowmya R. Rao, Department of
Surgery, School of Medicine, Boston University, Boston, MA, E-mail:
sowmya.rao@gmail.com. Amany H. Refaat, Walden University,
Minneapolis, MN, and Suez Canal University, Ismailia, Egypt,
E-mail: amany.refaat@waldenu.edu. Mark Riddle, Naval Medical
Research Center, Silver Spring, MD, E-mail: mark.s.riddle10
.mil@mail.mil. Gholamreza Roshandel, Golestan Research Center
of Gastroenterology and Hepatology, Golestan University of Medical
Sciences, Gorgan, Iran, and Digestive Disease Research Institute,
Tehran University of Medical Sciences, Tehran, Iran, E-mail:
roshandel_md@yahoo.com. George Mugambage Ruhago, Muhimbili
University of Health and Allied Sciences, Dar es Salaam, Tanzania,
E-mail: ruhagogm@gmail.com. Muhammad Muhammad Saleh,
Development Research and Projects Center, Abuja, Nigeria, E-mail:
docmmsaleh@yahoo.com. Juan R. Sanabria, Department of Surgery
and Comprehensive Cancer Center, Joan C. Edwards School of
Medicine, Marshall University, Huntington, WV, and Case Western
Reserve University, Cleveland, OH, E-mail: juan.sanabria@case.edu.
Monika Sawhney, Marshall University, Huntington, WV, E-mail:
msawhne@gmail.com. Tesfaye Setegn and Muluken A. Yenesew, Bahir
Dar University, Bahir Dar, Ethiopia, E-mails: tesfayesetegn@yahoo
.com and mulukenag@yahoo.com. Karen Sliwa, Faculty of Health
Sciences, Hatter Institute for Cardiovascular Research in Africa,
University of Cape Town, Cape Town, South Africa, E-mail: karen
.sliwa-hahnle@uct.ac.za. Chandrashekhar T. Sreeramareddy, Depart-
ment of Community Medicine, International Medical University,
Kuala Lumpur, Malaysia, E-mail: chandrashekharats@yahoo.com.
Bryan L. Sykes, Department of Criminology, Law and Society, Uni-
versity of California-Irvine, Irvine, CA, and Department of Socio-
logy, Public Health, University of California-Irvine, Irvine, CA,
E-mail: blsykes@uci.edu. Mohammad Tavakkoli, Westchester Medi-
cal Center, Valhalla, NY, E-mail: mtavakko@gmail.com. Bemnet
Amare Tedla, University of Gondar, Gondar, Ethiopia, and James
Cook University, Cairns, Australia, E-mail: amarebem6@gmail.com.
Abdullah S. Terkawi, Department of Anesthesiology, University
of Virginia, Charlottesville, VA, Outcomes Research Consortium,
Cleveland Clinic, Cleveland, OH, and Department of Anesthesi-
ology, King Fahad Medical City, Riyadh, Saudi Arabia, E-mail:
asterkawi@gmail.com. Kingsley Ukwaja, Department of Internal
Medicine, Federal Teaching Hospital, Abakaliki, Nigeria, E-mail:
ukwajakingsley@yahoo.co.uk. Olalekan A. Uthman, Warwick Medi-
cal School, University of Warwick, Coventry, United Kingdom,
E-mail: olalekan.uthman@warwick.ac.uk. Ronny Westerman, Federal
Institute for Population Research, Wiesbaden, Germany, and German
National Cohort Consortium, Heidelberg, Germany, E-mail: ronny.
westerman@bib.bund.de. Mamo Wubshet, University of Gondar,
Gondar, Ethiopia, and Addis Continental Institute of Public Health,
Addis Ababa, Ethiopia, E-mail: mamowubshet@gmail.com. Naohiro
Yonemoto, Department of Biostatistics, School of Public Health,
Kyoto University, Kyoto, Japan, E-mail: nyonemoto@gmail.com.
Mustafa Z. Younis, Jackson State University, Jackson, MS, E-mail:
younis99@gmail.com. Zoubida Zaidi, University Hospital, Setif,
Algeria, E-mail: zozaidi@yahoo.fr. Maysaa El Sayed Zaki, Faculty
of Medicine, Mansoura University, Mansoura, Egypt, E-mail:
may_s65@hotmail.com. Alan D. Lopez, Melbourne School of Popu-
lation and Global Health, University of Melbourne, Melbourne,
Australia, and Institute for Health Metrics and Evaluation, Univer-
sity of Washington, Seattle, WA, E-mail: alan.lopez@unimelb.edu.au.
This is an open-access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the
original author and source are credited.
REFERENCES
1. GBD 2013 Mortality and Causes of Death Collaborators, 2015.
Global, regional, and national age-sex specific all-cause and
cause-specific mortality for 240 causes of death, 1990–2013:
a systematic analysis for the Global Burden of Disease Study
2013. Lancet 385: 117–171.
2. Guerrant RL, DeBoer MD, Moore SR, Scharf RJ, Lima AAM,
2012. The impoverished gut: a triple burden of diarrhoea,
stunting and chronic disease. Nat Rev Gastroenterol Hepatol
10: 220–229.
3. Lindsay B, Saha D, Sanogo D, Das SK, Omore R, Farag TH,
Nasrin D, Li S, Panchalingam S, Levine MM, Kotloff K,
Nataro JP, Magder L, Hungerford L, Faruque ASG, Oundo J,
Hossain MA, Adeyemi M, Stine OC, 2015. Association
between Shigella infection and diarrhea varies based on loca-
tion and age of children. Am J Trop Med Hyg 93: 918–924.
4. Panchalingam S, Antonio M, Hossain A, Mandomando I,
Ochieng B, Oundo J, Ramamurthy T, Tamboura B, Zaidi
AKM, Petri W, Houpt E, Murray P, Prado V, Vidal R, Steele
D, Strockbine N, Sansonetti P, Glass RI, Robins-Browne RM,
Tauschek M, Svennerholm A-M, Kotloff K, Levine MM,
Nataro JP, 2012. Diagnostic microbiologic methods in the
GEMS-1 case/control study. Clin Infect Dis Off Publ Infect
Dis Soc Am 55: S294–S302.
5. The World Bank, 2016. GNI Per Capita, PPP (Current Interna-
tional $). Available at: http://data.worldbank.org/indicator/NY
.GNP.PCAP.PP.CD. Accessed March 15, 2016.
6. Enzley S, Barros F, 1997. A Global Review of Diarrhoeal Disease
Control. New York, NY: United Nations International Chil-
dren’s Emergency Fund. Available at: http://www.unicef.org/
french/evaldatabase/files/Global_1997_A_Global_Review.pdf.
Accessed April 1, 2016.
1327BURDEN OF DIARRHEA IN THE EMR, 1990–2013
7. World Health Organization, 1992. Programme for Control
of Diarrhoeal Diseases: Eight Programme Report, 1990–1991.
Geneva, Switzerland: World Health Organization.
8. Cobb LK, Baer FC, Debay MJ, ElFeraly MA, Kashmiry A,
1996. Final Assessment of the Egypt Child Survival Project
(263-0203). U.S. Agency for International Development.
Available at: http://pdf.usaid.gov/pdf_docs/Pdabn167.pdf.
Accessed March 23, 2016.
9. National Control of Diarrhoeal Diseases Project, 1988. Impact of
the National Control of Diarrhoeal Diseases Project on infant
and child mortality in Dakahlia, Egypt. Lancet 2: 145–148.
10. el-Rafie M, Hassouna WA, Hirschhorn N, Loza S, Miller P,
Nagaty A, Nasser S, Riyad R, 1990. Effect of diarrhoeal dis-
ease control on infant and childhood mortality in Egypt:
report from the National Control of Diarrheal Diseases Pro-
ject. Lancet 335: 334–338.
11. Forsberg BC, Petzold MG, Tomson G, Allebeck P, 2007. Diar-
rhoea case management in low-and middle-income countries:
an unfinished agenda. Bull World Health Organ 85: 42–48.
12. PATH, 2016. Rotavirus Vaccine Access and Delivery. Available
at: http://sites.path.org/rotavirusvaccine/country-introduction-
maps-and-spreadsheet/. Accessed March 15, 2016.
13. Foreman KJ, Lozano R, Lopez AD, Murray CJ, 2012. Modeling
causes of death: an integrated approach using CODEm. Popul
Health Metr 10: 1.
14. Flaxman A, Murray C, Vos T, eds., 2014. Integrated Meta-Regression
Framework for Descriptive Epidemiology. Seattle, WA: University
of Washington Press.
15. GBD 2013 DALYs and HALE Collaborators, Murray CJL,
Barber RM, Foreman KJ, Abbasoglu Ozgoren A, Abd-Allah
F, Abera SF, Aboyans V, Abraham JP, Abubakar I, Abu-
Raddad LJ, Abu-Rmeileh NM, Achoki T, Ackerman IN,
Ademi Z, Adou AK, Adsuar JC, Afshin A, Agardh EE,
Alam SS, Alasfoor D, Albittar MI, Alegretti MA, Alemu ZA,
Alfonso-Cristancho R, Alhabib S, Ali R, Alla F, Allebeck P,
Almazroa MA, Alsharif U, Alvarez E, Alvis-Guzman N,
Amare AT, Ameh EA, Amini H, Ammar W, Anderson HR,
Anderson BO, Antonio CAT, Anwari P, Arnlöv J, Arsic
Arsenijevic VS, Artaman A, Asghar RJ, Assadi R, Atkins LS,
Avila MA, Awuah B, Bachman VF, Badawi A, Bahit MC,
Balakrishnan K, Banerjee A, Barker-Collo SL, Barquera S,
Barregard L, Barrero LH, Basu A, Basu S, Basulaiman MO,
Beardsley J, Bedi N, Beghi E, Bekele T, Bell ML, Benjet C,
Bennett DA, Bensenor IM, Benzian H, Bernabé E, Bertozzi-
Villa A, Beyene TJ, Bhala N, Bhalla A, Bhutta ZA, Bienhoff
K, Bikbov B, Biryukov S, Blore JD, Blosser CD, Blyth FM,
Bohensky MA, Bolliger IW, Bora Başara B, Bornstein NM,
Bose D, Boufous S, Bourne RRA, Boyers LN, Brainin M,
Brayne CE, Brazinova A, Breitborde NJK, Brenner H, Briggs
AD, Brooks PM, Brown JC, Brugha TS, Buchbinder R,
Buckle GC, Budke CM, Bulchis A, Bulloch AG, Campos-
Nonato IR, Carabin H, Carapetis JR, Cárdenas R, Carpenter
DO, Caso V, Castañeda-Orjuela CA, Castro RE, Catalá-
López F, Cavalleri F, Çavlin A, Chadha VK, Chang JC,
Charlson FJ, Chen H, Chen W, Chiang PP, Chimed-Ochir O,
Chowdhury R, Christensen H, Christophi CA, Cirillo M, Coates
MM, Coffeng LE, Coggeshall MS, Colistro V, Colquhoun SM,
Cooke GS, Cooper C, Cooper LT, Coppola LM, Cortinovis
M, Criqui MH, Crump JA, Cuevas-Nasu L, Danawi H,
Dandona L, Dandona R, Dansereau E, Dargan PI, Davey G,
Davis A, Davitoiu DV, Dayama A, De Leo D, Degenhardt L,
Del Pozo-Cruz B, Dellavalle RP, Deribe K, Derrett S, Des
Jarlais DC, Dessalegn M, Dharmaratne SD, Dherani MK,
Diaz-Torné C, Dicker D, Ding EL, Dokova K, Dorsey ER,
Driscoll TR, Duan L, Duber HC, Ebel BE, Edmond KM,
Elshrek YM, Endres M, Ermakov SP, Erskine HE, Eshrati B,
Esteghamati A, Estep K, Faraon EJ, Farzadfar F, Fay DF,
Feigin VL, Felson DT, Fereshtehnejad SM, Fernandes JG,
Ferrari AJ, Fitzmaurice C, Flaxman AD, Fleming TD, Foigt
N, Forouzanfar MH, Fowkes FG, Paleo UF, Franklin RC,
Fürst T, Gabbe B, Gaffikin L, Gankpé FG, Geleijnse JM,
Gessner BD, Gething P, Gibney KB, Giroud M, Giussani G,
Gomez Dantes H, Gona P, González-Medina D, Gosselin RA,
Gotay CC, Goto A, Gouda HN, Graetz N, Gugnani HC,
Gupta R, Gupta R, Gutiérrez RA, Haagsma J, Hafezi-
Nejad N, Hagan H, Halasa YA, Hamadeh RR, Hamavid H,
Hammami M, Hancock J, Hankey GJ, Hansen GM, Hao Y,
Harb HL, Haro JM, Havmoeller R, Hay SI, Hay RJ, Heredia-
Pi IB, Heuton KR, Heydarpour P, Higashi H, Hijar M, Hoek
HW, Hoffman HJ, Hosgood HD, Hossain M, Hotez PJ, Hoy
DG, Hsairi M, Hu G, Huang C, Huang JJ, Husseini A, Huynh
C, Iannarone ML, Iburg KM, Innos K, Inoue M, Islami F,
Jacobsen KH, Jarvis DL, Jassal SK, Jee SH, Jeemon P, Jensen
PN, Jha V, Jiang G, Jiang Y, Jonas JB, Juel K, Kan H, Karch
A, Karema CK, Karimkhani C, Karthikeyan G, Kassebaum
NJ, Kaul A, Kawakami N, Kazanjan K, Kemp AH, Kengne
AP, Keren A, Khader YS, Khalifa SE, Khan EA, Khan G,
Khang YH, Kieling C, Kim D, Kim S, Kim Y, Kinfu Y, Kinge
JM, Kivipelto M, Knibbs LD, Knudsen AK, Kokubo Y, Kosen
S, Krishnaswami S, Kuate Defo B, Kucuk Bicer B, Kuipers
EJ, Kulkarni C, Kulkarni VS, Kumar GA, Kyu HH, Lai T,
Lalloo R, Lallukka T, Lam H, Lan Q, Lansingh VC, Larsson
A, Lawrynowicz AE, Leasher JL, Leigh J, Leung R, Levitz
CE, Li B, Li Y, Li Y, Lim SS, Lind M, Lipshultz SE, Liu S,
Liu Y, Lloyd BK, Lofgren KT, Logroscino G, Looker KJ,
Lortet-Tieulent J, Lotufo PA, Lozano R, Lucas RM,
Lunevicius R, Lyons RA, Ma S, Macintyre MF, Mackay MT,
Majdan M, Malekzadeh R, Marcenes W, Margolis DJ,
Margono C, Marzan MB, Masci JR, Mashal MT, Matzopoulos
R, Mayosi BM, Mazorodze TT, Mcgill NW, Mcgrath JJ,
Mckee M, Mclain A, Meaney PA, Medina C, Mehndiratta
MM, Mekonnen W, Melaku YA, Meltzer M, Memish ZA,
Mensah GA, Meretoja A, Mhimbira FA, Micha R, Miller
TR, Mills EJ, Mitchell PB, Mock CN, Mohamed Ibrahim
N, Mohammad KA, Mokdad AH, Mola GL, Monasta L,
Montañez Hernandez JC, Montico M, Montine TJ, Mooney
MD, Moore AR, Moradi-Lakeh M, Moran AE, Mori R,
Moschandreas J, Moturi WN, Moyer ML, Mozaffarian D,
Msemburi WT, Mueller UO, Mukaigawara M, Mullany EC,
Murdoch ME, Murray J, Murthy KS, Naghavi M, Naheed A,
Naidoo KS, Naldi L, Nand D, Nangia V, Narayan KM, Nejjari
C, Neupane SP, Newton CR, Ng M, Ngalesoni FN, Nguyen
G, Nisar MI, Nolte S, Norheim OF, Norman RE, Norrving B,
Nyakarahuka L, Oh IH, Ohkubo T, Ohno SL, Olusanya BO,
Opio JN, Ortblad K, Ortiz A, Pain AW, Pandian JD, Panelo
CI, Papachristou C, Park EK, Park JH, Patten SB, Patton
GC, Paul VK, Pavlin BI, Pearce N, Pereira DM, Perez-Padilla
R, Perez-Ruiz F, Perico N, Pervaiz A, Pesudovs K, Peterson
CB, Petzold M, Phillips MR, Phillips BK, Phillips DE, Piel
FB, Plass D, Poenaru D, Polinder S, Pope D, Popova S,
Poulton RG, Pourmalek F, Prabhakaran D, Prasad NM,
Pullan RL, Qato DM, Quistberg DA, Rafay A, Rahimi K,
Rahman SU, Raju M, Rana SM, Razavi H, Reddy KS, Refaat
A, Remuzzi G, Resnikoff S, Ribeiro AL, Richardson L,
Richardus JH, Roberts DA, Rojas-Rueda D, Ronfani L, Roth
GA, Rothenbacher D, Rothstein DH, Rowley JT, Roy N,
Ruhago GM, Saeedi MY, Saha S, Sahraian MA, Sampson
UK, Sanabria JR, Sandar L, Santos IS, Satpathy M, Sawhney
M, Scarborough P, Schneider IJ, Schöttker B, Schumacher
AE, Schwebel DC, Scott JG, Seedat S, Sepanlou SG, Serina
PT, Servan-Mori EE, Shackelford KA, Shaheen A, Shahraz S,
Shamah Levy T, Shangguan S, She J, Sheikhbahaei S, Shi P,
Shibuya K, Shinohara Y, Shiri R, Shishani K, Shiue I,
Shrime MG, Sigfusdottir ID, Silberberg DH, Simard EP,
Sindi S, Singh A, Singh JA, Singh L, Skirbekk V, Slepak
EL, Sliwa K, Soneji S, Søreide K, Soshnikov S, Sposato LA,
Sreeramareddy CT, Stanaway JD, Stathopoulou V, Stein DJ,
Stein MB, Steiner C, Steiner TJ, Stevens A, Stewart A,
Stovner LJ, Stroumpoulis K, Sunguya BF, Swaminathan S,
Swaroop M, Sykes BL, Tabb KM, Takahashi K, Tandon
N, Tanne D, Tanner M, Tavakkoli M, Taylor HR, Te Ao
BJ, Tediosi F, Temesgen AM, Templin T, Ten Have M,
Tenkorang EY, Terkawi AS, Thomson B, Thorne-Lyman AL,
Thrift AG, Thurston GD, Tillmann T, Tonelli M, Topouzis F,
Toyoshima H, Traebert J, Tran BX, Trillini M, Truelsen
T, Tsilimbaris M, Tuzcu EM, Uchendu US, Ukwaja KN,
Undurraga EA, Uzun SB, Van Brakel WH, Van De Vijver S,
van Gool CH, Van Os J, Vasankari TJ, Venketasubramanian
N, Violante FS, Vlassov VV, Vollset SE, Wagner GR, Wagner
J, Waller SG, Wan X, Wang H, Wang J, Wang L, Warouw TS,
1328 KHALIL AND OTHERS
Weichenthal S, Weiderpass E, Weintraub RG, Wenzhi W,
Werdecker A, Westerman R, Whiteford HA, Wilkinson JD,
Williams TN, Wolfe CD, Wolock TM, Woolf AD, Wulf S,
Wurtz B, Xu G, Yan LL, Yano Y, Ye P, Yentür GK, Yip P,
Yonemoto N, Yoon SJ, Younis MZ, Yu C, Zaki ME, Zhao Y,
Zheng Y, Zonies D, Zou X, Salomon JA, Lopez AD, Vos T,
2015. Global, regional, and national disability-adjusted life
years (DALYs) for 306 diseases and injuries and healthy life
expectancy (HALE) for 188 countries, 1990–2013: quantifying
the epidemiological transition. Lancet 386: 2145–2191.
16. Global Burden of Disease Study 2013 Collaborators, 2015.
Global, regional, and national incidence, prevalence, and years
lived with disability for 301 acute and chronic diseases and inju-
ries in 188 countries, 1990–2013: a systematic analysis for the
Global Burden of Disease Study 2013. Lancet 386: 743–800.
17. Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH,
Panchalingam S, Wu Y, Sow SO, Sur D, Breiman RF, Faruque
AS, Zaidi AK, Saha D, Alonso PL, Tamboura B, Sanogo D,
Onwuchekwa U, Manna B, Ramamurthy T, Kanungo S,
Ochieng JB, Omore R, Oundo JO, Hossain A, Das SK,
Ahmed S, Qureshi S, Quadri F, Adegbola RA, Antonio M,
Hossain MJ, Akinsola A, Mandomando I, Nhampossa T,
Acácio S, Biswas K, O’Reilly CE, Mintz ED, Berkeley LY,
Muhsen K, Sommerfelt H, Robins-Browne RM, Levine MM,
2013. Burden and aetiology of diarrhoeal disease in infants and
young children in developing countries (the Global Enteric
Multicenter Study, GEMS): a prospective, case-control study.
Lancet 382: 209–222.
18. Wickham H, 2009. ggplot2: Elegant Graphics for Data Analysis.
New York, NY: Springer-Verlag.
19. Boschi-Pinto C, Velebit L, Shibuya K, 2008. Estimating child
mortality due to diarrhoea in developing countries. Bull World
Health Organ 86: 710–717.
20. Walker CLF, Rudan I, Liu L, Nair H, Theodoratou E, Bhutta
ZA, O’Brien KL, Campbell H, Black RE, 2013. Global bur-
den of childhood pneumonia and diarrhoea. Lancet Lond
Engl 381: 1405–1416.
21. Javanbakht M, Moradi-Lakeh M, Yaghoubi M, Esteghamati A,
Mansour Ghanaie R, Mahmoudi S, Shamshiri A-R, Zahraei
SM, Baxter L, Shakerian S, Chaudhri I, Fleming JA, Munier A,
Baradaran HR, 2015. Cost-effectiveness analysis of the intro-
duction of rotavirus vaccine in Iran. Vaccine 33: A192–A200.
22. Connolly MP, Topachevskyi O, Standaert B, Ortega O, Postma
M, 2012. The impact of rotavirus vaccination on discounted
net tax revenue in Egypt: a government perspective analysis.
Pharmacoeconomics 30: 681–695.
23. Ortega O, El-‐Sayed N, Sanders JW, Abd-‐Rabou Z, Antil L,
Bresee J, Mansour A, Adib I, Nahkla I, Riddle MS, 2009.
Cost-benefit analysis of a rotavirus immunization program in
the Arab Republic of Egypt. J Infect Dis 200: S92–S98.
24. Gargano LM, Tate JE, Parashar UD, Omer SB, Cookson ST,
2015. Comparison of impact and cost-effectiveness of rota-
virus supplementary and routine immunization in a com-
plex humanitarian emergency, Somali case study. Confl
Health 9: 5.
25. Walker CLF, Perin J, Aryee MJ, Boschi-Pinto C, Black RE,
2012. Diarrhea incidence in low-and middle-income countries
in 1990 and 2010: a systematic review. BMC Public Health
12: 220.
26. Trinh C, Prabhakar K, 2007. Diarrheal diseases in the elderly.
Clin Geriatr Med 23: 833–856 vii.
27. Hill K, Upchurch DM, 1995. Gender differences in child health:
evidence from the demographic and health surveys. Popul
Dev Rev 21: 127.
28. Yount KM, 2003. Provider bias in the treatment of diarrhea
among boys and girls attending public facilities in Minia,
Egypt. Soc Sci Med 56: 753–768.
29. Awqati NA, Ali MM, Al-Ward NJ, Majeed FA, Salman K, Al-
Alak M, Al-Gasseer N, 2009. Causes and differentials of
childhood mortality in Iraq. BMC Pediatr 9: 40.
30. Moore SR, Lima NL, Soares AM, Oriá RB, Pinkerton RC,
Barrett LJ, Guerrant RL, Lima AAM, 2010. Prolonged
episodes of acute diarrhea reduce growth and increase risk
of persistent diarrhea in children. Gastroenterology 139:
1156–1164.
31. MacIntyre J, McTaggart J, Guerrant RL, Goldfarb DM, 2014.
Early childhood diarrhoeal diseases and cognition: are we
missing the rest of the iceberg? Paediatr Int Child Health 34:
295–307.
32. Liu J, Kabir F, Manneh J, Lertsethtakarn P, Begum S, Gratz J,
Becker SM, Operario DJ, Taniuchi M, Janaki L, Platts-Mills
JA, Haverstick DM, Kabir M, Sobuz SU, Nakjarung K,
Sakpaisal P, Silapong S, Bodhidatta L, Qureshi S, Kalam A,
Saidi Q, Swai N, Mujaga B, Maro A, Kwambana B, Dione M,
Antonio M, Kibiki G, Mason CJ, Haque R, Iqbal N, Zaidi
AK, Houpt ER, 2014. Development and assessment of molec-
ular diagnostic tests for 15 enteropathogens causing childhood
diarrhoea: a multicentre study. Lancet Infect Dis 14: 716–724.
33. Malek MA, Teleb N, Abu-‐Elyazeed R, Riddle MS, Sherif ME,
Steele AD, Glass RI, Bresee JS, 2010. The epidemiology of
rotavirus diarrhea in countries in the Eastern Mediterranean
Region. J Infect Dis 202: S12–S22.
1329BURDEN OF DIARRHEA IN THE EMR, 1990–2013
